- Report
- October 2024
- 199 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- February 2024
- 280 Pages
Global
From €5429EUR$5,693USD£4,350GBP
- Report
- June 2024
- 41 Pages
Global
From €2467EUR$2,499USD£2,045GBP
- Report
- September 2024
- 247 Pages
Global
From €2418EUR$2,450USD£2,005GBP
- Report
- October 2024
- 187 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 197 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 185 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 189 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 180 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 191 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 196 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 182 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 188 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 196 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 180 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 181 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 196 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 198 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 187 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
- Report
- October 2024
- 197 Pages
Global
From €3499EUR$3,545USD£2,902GBP
€3888EUR$3,939USD£3,224GBP
The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more